The World Health Organization (WHO) updated the fourth edition of the Guidelines for treatment of tuberculosis published in 2010.
The Global TB Programme of the World Health Organization convened a meeting of a Guidelines Development Group on 11-13 July 2016 in Geneva, Switzerland in order to review the evidence available on key aspects of the treatment of drug-susceptible TB, as well as of patient care and to formulate recommendations for the update of the fourth edition of theGuidelines for treatment of tuberculosis published in 2010.
As a result, an updated version of the document has been released, Guidelines for treatment of drug-susceptible tuberculosis and patient care. The new document aims to use the best available evidence on the treatment of drug-susceptible TB and interventions to ensure adequate patient care and support in order to inform policy decisions made in these technical areas by national TB control programme managers, national policy-makers and medical practitioners in a variety of geographical, economic and social settings.[gview file=”http://ecuo.org/mvdev/wp-content/uploads/sites/4/2017/04/who_guidelines.pdf”]